Purpose Outpatient care for patients with cancer compromises 60% to 70% of health care
costs during the last 6 months of life. Recent approvals for expensive biologics and growing …

Importance Despite recommendations to reduce intensive medical treatment at the end of
life, many patients with cancer continue to receive such services. Objective To quantify …

Health economics is a tricky business, especially for cancer. On one hand, no monetary cost
is commensurate to the saving of a life or providing hope against an insidious disease. On …

BACKGROUND/OBJECTIVES To evaluate differences in end‐of‐life cost trajectories for
cancer patients treated through Medicare versus by the Veterans Health Administration (VA) …

Purpose: The Oncology Care Model (OCM) is a highly controversial specialty care model
developed by the Centers for Medicare & Medicaid aimed to provide higher-quality care at …

Purpose The aim of this study was to estimate Medicare payments for cancer care during the
initial, continuing, and end‐of‐life phases of care for 10 malignancies and to examine …

Purpose: With rising health care costs in the United States, clearly defined end-of-life (EOL)
cancer costs are needed to help health administrators proactively manage this important …

BACKGROUND A significant share of the cost of cancer care is concentrated in the end‐of‐
life period. Although quality measures of aggressive treatment may guide optimal care …

Purpose: To assess the impact of 2005 and 2006 reductions in chemotherapy
reimbursement, mandated in the Medicare Modernization Act, on patterns of chemotherapy …

Background Medicare cancer expenditures in the last month of life have increased.
Aggressive cancer care at the end-of-life (ACEOL) is considered poor quality care. We used …